Hollencrest Capital Management Bio N Tech Se Transaction History

Hollencrest Capital Management

  • $2.17 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 07, 2022
SELL
$216.64 - $362.52 $196,492 - $328,805
-907 Closed
0 $0
Q3 2021

Oct 13, 2021
SELL
$205.93 - $447.23 $61,779 - $134,169
-300 Reduced 24.86%
907 $248,000
Q2 2021

Jul 21, 2021
BUY
$113.32 - $241.49 $136,777 - $291,478
1,207 New
1,207 $270,000

Others Institutions Holding BNTX

# of Institutions
327
Shares Held
40.4M
Call Options Held
1.31M
Put Options Held
1.37M
View Full List

About BioNTech SE

BNTX Quotes by TradingView
  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $19.4B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Hollencrest Capital Management Portfolio

Follow Hollencrest Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hollencrest Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Hollencrest Capital Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email